BURBANK, Calif., July 26, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG) today provided insight into one of the many health care sectors where the company's breakthrough, multi-modality, mobile and real-time 3D imaging technology will have a powerful impact -- orthopedic surgery. The Dominion(tm) will aid patient and doctor alike in this $8.8 billion annual U.S. market that is expected to grow to nearly $14 billion by 2010, according to Datamonitor, New York, NY.
The Dominion(tm) will be uniquely well-suited to the operating room for all types of surgery but is especially notable in orthopedic procedures. Foremost, The Dominion(tm) provides the surgeon with three-dimensional images in real-time, which will allow viewing the patient from an almost infinite number of angles without the need to reorient either the patient or the equipment. With current technology, orthopedic surgeons must realign the patient, imaging equipment, and/or imaging table throughout various stages of the procedure. Reducing or eliminating these steps in the surgical process speeds the operation, thereby decreasing the time the patient must be kept under anesthesia and reducing recovery time due to less trauma.
Imaging3's CEO Dean Janes stated, "Further advantages of Imaging3's breakthrough technology in the operating room are due to the mobility of The Dominion(tm), its relatively small footprint in a crowded operating room setting and its ability to offer doctors multiple imaging options. The multi-modality role that The Dominion(tm) will play provides surgical teams with tools that were not previously possible, with its ability to emulate CT Scanners being a prime example. This ability, combined with real-time 3D and fluoroscopy (x-ray) imaging, gives surgeons unprecedented capabilities that will leverage their skills to the fullest and to the benefit of their patients' surgical outcome."
"The combination of dramatic growth in the number of orthopedic procedures performed, the rising prices of new orthopedic products, and the rising cost of overall healthcare is placing substantial pressure on practitioners and institutions by insurance providers and others responsible for payment to reign in costs. By reducing the expense associated with medical imaging combined with improved productivity of a hospital's most valuable people and assets, The Dominion(tm) will make a major contribution toward the goal of cost containment in the realm of orthopedic surgery," stated Dean Janes, Imaging3 CEO.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com for more information.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.